Skip to main content

Time to brush up on your science fiction



Paul Krugman would stand in line to meet Charlie Stross. The Nobel Prize-winning economist who spoke at the Hindustan Times Leadership Summit last week is a sci-fi buff and, with the conviction of a true zealot looking for an argument (I’ve been there, so trust me), told me that the British writer is the best science fiction writer alive. This was at a pre-summit dinner and the small group that had gathered around Krugman—managers of private equity funds, CEOs of global and local companies—didn’t really seem to care. Later that evening, we briefly discussed the economics and probability of commercial space travel of the kind that could enable the colonization of Mars.

That we were having a serious discussion on what was once a popular theme in sci-fi (Mars books are legion) is a sign of the times. Towards the end of the tumultuous decade that started in 2008, and characterized by flat-lining incomes, the rise of authoritarian leaders selling simple (and usually shallow, but very popular) ideas, and general unhappiness and strife, it is clear that everyone, including economists, needs to accept that the future is upon us. Indeed, in recent years we have seen a profusion of literature trying to understand what would happen if the homo economicus (or the economic and rational human) is replaced by machina economicus (an interpretative translation would be the perfectly rational machine).

For the benefit of those who have been away on Mars, let’s make a list. In the ongoing decade since 2008, artificial intelligence (AI) has finally stopped being a buzzword and become reality thanks to what is called deep learning (simply put, teaching a machine to think and learn); self-driving cars have been launched; advances in gene-editing have put the 100-year life (borrowed from the title of a book on what longevity means to life and work by Andrew Scott and Lynda Gratton) within our grasp, and AR and VR (augmented and virtual reality) are disrupting everything from pornography to education (although, sometimes, pornography is educative). I’ve left out the more ordinary innovations including homes that think, phones that talk back, robots that greet you at stores, transparent yet secure ledgers of everything (as some have described blockchain) or household 3D printers.

Pause for a moment and think. And then, if you want to, trivialize. I am told there are no queues in Mars.

I’d like to call this an ex machina moment for businesses. Start-ups and incumbents that understand the power and utility of these technologies will be able to write the new rules of business and define not just industry standards but industries themselves. For instance, AI could take away 60-80% of service sector jobs. That voice at the other end of the line when you call your bank (if you are one of those who still calls banks) could soon belong to an intelligent agent. How soon? Yesterday.

Where would we find such companies? Actually, all around us, and even in India (and I use the word even not as an expression of disparagement but with a sense of pride because one would typically expect to find such companies in the US, Japan, or the country with the most digital society in the world, South Korea). Within a 25km radius of the Hindustan Times newsroom in central Delhi is a start-up that makes industrial robots. There are a few dozen companies in the country working in the area of AI, including a handful that would be recognized as true AI companies anywhere in the world. Mint has been profiling some of these companies as part of its Mint40 series, an ongoing listing that also covers popular companies that do not use cutting-edge technologies but which could dominate the country’s business landscape in the 2020s. As the name suggests, the listing will have 40 companies—40 companies that could well constitute an index of the future.

In the 1990s, pharma firms such as Dr Reddy’s Laboratories and IT companies such as Infosys were among the bright lights in this landscape (although both companies were founded earlier). In the 2000s, it was telcos such as Bharti Airtel Ltd. And in the 2010s, this role \was taken up by the e-commerce marketplaces. Capital and the best human resources gravitated towards them. They received glowing (and sometimes gushing) media coverage. And they were valued disproportionately.

This doesn’t mean today’s large companies will simply roll over and die. The smarter ones among these—one example is industrial conglomerate General Electric—are already reinventing themselves, using their existing and obvious advantages to innovate, define standards, even acquire hot start-ups. But, at the risk of repetition, disproportionate value will be created by start-ups in these new areas.

That’s why smart venture capitalists, analysts, journalists and job-seekers would do well to brush up on their science fiction.

Comments

Popular posts from this blog

NGT terminates chairmen of pollution control boards in 10 states (downtoearth,)

Cracking the whip on 10 State Pollution Control Boards (SPCBs) for ad-hoc appointments, the National Green Tribunal has ordered the termination of Chairpersons of these regulatory authorities. The concerned states are Himachal Pradesh, Sikkim, Tamil Nadu, Uttarakhand, Kerala, Rajasthan, Telangana, Haryana, Maharashtra and Manipur. The order was given last week by the principal bench of the NGT, chaired by Justice Swatanter Kumar. The recent order of June 8, 2017, comes as a follow-up to an NGT judgment given in August 2016. In that judgment, the NGT had issued directions on appointments of Chairmen and Member Secretaries of the SPCBs, emphasising on crucial roles they have in pollution control and abatement. It then specified required qualifications as well as tenure of the authorities. States were required to act on the orders within three months and frame Rules for appointment [See Box: Highlights of the NGT judgment of 2016 on criteria for SPCB chairperson appointment]. Having

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”. The Supreme Court on Friday came close to ordering the government not to deport the Rohingya. It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests. The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach i